Bisoprolol fumarate
Bibloc belongs to a group of medicines called beta-blockers. They protect the heart from excessive activity.
Bibloc is used to treat:
high blood pressure
angina pectoris (chest pain)
heart failure, which causes shortness of breath during exertion or fluid retention in the body. In such cases, Bibloc may be used as additional treatment for heart failure, treated with other medicines.
If the patient is allergic to bisoprolol fumarate or any of the other ingredients of this medicine (listed in section 6).
If the patient has cardiogenic shock - a severe heart disorder with rapid, weak pulse, low blood pressure, cold, sweaty skin, weakness, and fainting.
If the patient has ever had wheezing or severe asthma, as breathing difficulties may occur.
If the patient has a slow heart rate (less than 60 beats per minute). In case of doubt, consult a doctor.
If the patient has very low blood pressure.
If the patient has severe circulatory disorders (which can cause tingling in the fingers and toes or their paleness or blueness).
If the patient has severe heart rhythm disorders.
If the patient has suddenly developed heart failure or existing heart failure is uncontrolled and requires hospital treatment.
If the patient has a buildup of acids in the body, diagnosed as metabolic acidosis. The doctor will provide information on this.
If the patient has a tumor of the adrenal gland (so-called pheochromocytoma) that is not being treated.
In case of any doubts, consult a doctor.
Before starting to take Bibloc, you should consult a doctor:
if you have wheezing or difficulty breathing (asthma), you should also take medicines that dilate the airways. A higher dose of beta-2-mimetic may be necessary.
if you have diabetes. Bibloc tablets may mask the symptoms of low blood sugar (such as rapid heartbeat, palpitations, or excessive sweating).
if you do not eat foods with a fixed consistency.
if you are being treated for allergies. Bibloc may increase sensitivity to allergens and worsen the severity of hypersensitivity reactions. Adrenaline treatment may then be ineffective and may need to be administered in a higher dose.
if you have first-degree atrioventricular block (conduction disorders in the heart).
if you have Prinzmetal's angina (chest pains caused by coronary artery spasm).
if you have circulatory disorders in your hands and feet.
if you are going to have surgery under anesthesia, you should inform your doctor, hospital staff, or dentist about the medicines you are taking.
if you are taking calcium channel blockers, such as verapamil and diltiazem. Concurrent use is not recommended (see also "Other medicines and Bibloc").
if you have had psoriasis (a recurring disease characterized by skin peeling and dry skin rash) in the past.
if you have a pheochromocytoma (adrenal gland tumor). Before prescribing Bibloc, the doctor will need to provide appropriate treatment.
if you have thyroid function disorders. Bisoprolol tablets may mask the symptoms of hyperthyroidism.
There is currently no therapeutic experience with the use of Bibloc in heart failure in the following patients:
Treatment of heart failure with Bibloc requires systematic medical supervision. This is absolutely necessary, especially at the beginning and end of treatment.
Do not stop taking Bibloc suddenly without a compelling reason.
In patients with high blood pressure and angina pectoris with concomitant heart failure, treatment should not be stopped abruptly. The dose of the medicine should be gradually reduced, by half every week.
Consult a doctor if any of the described warnings apply to you or have applied in the past.
Tell your doctor or pharmacist about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take. This also applies to medicines that are available without a prescription. Certain medicines cannot be taken at the same time as Bibloc, and others may require changes, such as dose adjustments.
In any case, inform your doctor about taking or receiving the following medicines in addition to Bibloc:
medicines used to control blood pressure or heart function disorders (such as amiodarone, amlodipine, clonidine, digitalis glycosides, diltiazem, disopyramide, felodipine, flecainide, lidocaine, methyldopa, moxonidine, phenytoin, propafenone, quinidine, rilmenidine, verapamil);
sedatives and medicines used to treat psychosis (mental illness), such as barbiturates (also used to treat epilepsy), phenothiazines (also used to treat vomiting and nausea);
medicines used to treat depression, such as tricyclic antidepressants, MAO-A inhibitors;
medicines used for anesthesia during surgery (see also "Warnings and precautions");
certain painkillers (such as acetylsalicylic acid, diclofenac, indomethacin, ibuprofen, naproxen);
medicines used to treat asthma, nasal congestion, or certain eye diseases, such as glaucoma (increased pressure in the eyeball) or pupil dilation;
certain medicines used to treat shock (such as adrenaline, dobutamine, noradrenaline);
mefloquine (a medicine used to treat malaria);
rifampicin (an antibiotic);
ergotamine derivatives (used to treat migraines).
All these medicines and Bibloc may affect blood pressure and/or heart function.
insulin or other anti-diabetic medicines. There is a possibility of enhanced glucose-lowering effect and masking of symptoms of low blood sugar.
Alcohol may enhance the dizziness and fainting caused by Bibloc. In such cases, you should avoid drinking alcohol.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult a doctor before taking this medicine. Bibloc may have a harmful effect on the course of pregnancy and/or the fetus. The risk of premature birth, miscarriage, low blood sugar in the child, and slowing of the child's heart rate increases. The medicine may also affect the development of the child. For this reason, Bibloc should not be taken during pregnancy.
It is not known whether bisoprolol passes into breast milk, so it is not recommended to take Bibloc during breastfeeding.
The medicine may cause fatigue, drowsiness, or dizziness. If these symptoms occur, you should not drive vehicles and/or operate machines. Keep in mind that such symptoms may occur, especially at the beginning of treatment, when changing to another medicine, and when consuming alcohol.
If you have previously been diagnosed with intolerance to certain sugars, you should contact your doctor before taking the medicine.
This medicine contains less than 1 mmol (23 mg) of sodium per coated tablet, which means the medicine is considered "sodium-free".
This medicine should always be taken exactly as directed by your doctor or pharmacist. In case of doubt, consult a doctor or pharmacist.
The doctor will inform you how many tablets to take. The medicine should be taken in the morning, before, during, or after breakfast. The tablet(s) should be swallowed with a small amount of water. The tablets should not be chewed or crushed.
Adults
The doctor will determine the dose of the medicine individually.
The recommended initial dose is 5 mg once a day.
The usual dose for adults is 10 mg once a day. The doctor may decide to increase or decrease this dose.
The maximum dose is 20 mg once a day.
Severe kidney or liver function disorders
In patients with severe kidney function disorders:the maximum dose is 10 mg per day.
Elderly
Dose adjustment is not usually necessary. The doctor will start treatment with the lowest possible dose.
Before starting to take Bibloc, the patient usually already takes an ACE inhibitor, diuretic, or digitalis glycoside (a heart medicine and antihypertensive).
The dose of the medicine will be gradually increased until the appropriate dose for the patient is reached:
1.25 mg once a day for 1 week. If this dose is well tolerated, it can be increased to:
2.5 mg once a day for the next week. If this dose is well tolerated, it can be increased to:
3.75 mg once a day for the next week. If this dose is well tolerated, it can be increased to:
5 mg once a day for 4 consecutive weeks. If this dose is well tolerated, it can be increased to:
7.5 mg once a day for 4 consecutive weeks. If this dose is well tolerated, it can be increased to:
10 mg once a day (maintenance dose).
The maximum dose is 10 mg once a day.
The doctor will determine the optimal dose for the patient based on, among other things, side effects.
After administering the first dose of 1.25 mg, the doctor will check the patient's blood pressure, heart rate, and heart function.
Liver or kidney function disorders
The doctor will carefully increase the dose of the medicine.
Elderly
Dose adjustment is not usually necessary.
If you feel that the effect of Bibloc is too strong or too weak, you should inform your doctor or pharmacist.
Place the tablet on a hard, flat surface, with the notch facing up.
Press your thumb on the center of the tablet. The tablet will break into two halves. After pressing on the center of each half, you will get 4 parts.
Bibloc is usually taken for a long time.
Due to the lack of studies on the effect of Bibloc in children and adolescents, its use is not recommended in this age group.
In case of unintentional ingestion of a higher dose than recommended, you should immediately contact
a doctor or pharmacist. You should bring the remaining tablets or this leaflet with you, so that the medical staff knows what medicine has been taken. Symptoms of overdose may include dizziness, fainting, fatigue, shortness of breath and/or wheezing. There may also be slow heart rate, low blood pressure, inadequate heart contractions, and low blood sugar (which can cause hunger, excessive sweating, and palpitations).
You should not take a double dose to make up for a missed dose. You should take the usual dose as soon as you remember, and the next day return to the normal treatment schedule.
You should not stop taking Bibloc suddenly. If treatment is stopped abruptly, the disease may worsen. The dose of the medicine should be gradually reduced over several weeks, according to the doctor's instructions.
In case of any further doubts related to the use of this medicine, you should consult a doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If a side effect is serious, occurs suddenly, or worsens rapidly, you should immediately contact a doctor to prevent severe reactions.
The most serious side effects are related to heart function:
slow heart rate (may occur more frequently than in 1 in 10 people)
worsening of existing heart failure (may occur less frequently than in 1 in 10 people)
slow or irregular heart rate (may occur less frequently than in 1 in 100 people)
If you experience dizziness, weakness, or difficulty breathing, you should contact a doctor as soon as possible.
If you experience severe hypersensitivity reactions, which may include swelling of the face, neck, tongue, lips, or throat, or difficulty breathing, you should immediately contact a doctor.
The following side effects are listed below by frequency of occurrence:
Common (may occur less frequently than in 1 in 10 people):
fatigue. In the treatment of high blood pressure or angina pectoris, this side effect occurs infrequently.
dizziness, fatigue, and headache (especially at the beginning of treatment in patients with high blood pressure and angina pectoris; these symptoms are usually mild and often disappear within 1 to 2 weeks)
feeling of cold or numbness in the limbs (fingers or toes, ears, and nose); more frequent occurrence of cramping leg pain when walking
very low blood pressure (hypotension), especially in patients with heart failure
nausea, vomiting
diarrhea
constipation
Uncommon (may occur less frequently than in 1 in 100 people):
fatigue. In the treatment of heart failure, this side effect occurs frequently.
decrease in blood pressure when standing up, which may cause dizziness, fainting, or lightheadedness
sleep disorders
depression
irregular heart rate
breathing difficulties in patients with asthma or a history of breathing disorders
muscle weakness and cramps
Rare (may occur less frequently than in 1 in 1000 people):
nightmares
hallucinations
fainting
hearing impairment
nasal congestion, causing a runny nose with irritation
allergic skin reactions (such as itching, sudden redness of the skin, rash)
dryness of the eyes due to reduced tear secretion (which can be very troublesome for patients wearing contact lenses)
liver inflammation, causing abdominal pain, loss of appetite, and sometimes jaundice with yellowing of the eyes and skin, as well as dark urine
reduced sexual potency (impotence)
increased levels of lipids in the blood (triglycerides) and increased activity of liver enzymes
Very rare (may occur less frequently than in 1 in 10,000 people):
worsening of psoriasis symptoms or occurrence of a similar, dry, flaky skin rash, as well as hair loss
itching or redness of the eyes (conjunctivitis)
Reporting side effects
If you experience any side effects, including any side effects not listed in this leaflet, you should tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw
tel.: + 48 22 49 21 301/fax: + 48 22 49 21 309/website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging after EXP.
The expiry date refers to the last day of the month.
Do not use the medicine in the bottle after 6 months from the first opening.
Blister: There are no special precautions for storage.
Bottle: There are no special precautions for storage.
After first opening: Do not store above 25°C.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Round, orange-colored, coated tablets with a notch, marked "BIS 10" on one side.
The tablets can be divided into four equal doses.
The coated tablets are packaged in blisters of OPA/Aluminum/PVC/Aluminum foil or in HDPE bottles and placed in a cardboard box.
The blisters contain 30, 60, or 90 tablets.
The bottles contain 100 tablets.
Not all pack sizes may be marketed.
Marketing authorization holder
Sandoz GmbH
Biochemiestrasse 10
6250 Kundl, Austria
Manufacturer
Lek Pharmaceuticals d.d.
Verovškova 57
1526 Ljubljana, Slovenia
Lek S.A.
ul. Domaniewska 50 C
02-672 Warsaw
Rowa Pharmaceuticals Ltd.
Newtown, Bantry, Co. Cork, Ireland
Salutas Pharma GmbH
Otto-von-Guericke-Allee 1
D-39179 Barleben, Germany
Lek S.A.
ul. Podlipie 16
95-010 Stryków, Poland
Sandoz Poland Sp. z o.o.
ul. Domaniewska 50 C
02-672 Warsaw
Tel. 22 209 70 00
Date of last update of the leaflet:03/2022
Sandoz logo
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.